Is anyone interested in coming to work with the amazing crowd at the Cuella Martin lab and our cool projects?
An RA position will open soon, stay tuned!
We are thrilled to share that the @US_FDA granted Fast Track designation to the lunresertib-camonsertib combination for the treatment of platinum-resistant ovarian cancer. Learn more here: https://t.co/dAnDm4YWJC #precisiononcology#fasttrackdesignation#ovariancancer
What a unique and great meeting this was, not even north of 32 mosquito bites detracted from the amazing science discussed! Thanks to organizers @raquel_cuella@AAlvandro@durocher1 for their hard work!
We conclude the very First Bellairs workshop on Genome Engineering and Repair. What a great week of scientific discussions in such a unique place. Amazing crowd!! Barbados, we will be back!
Don't miss Ale's presentation on Saturday at the 6th DNA Repair/Replication Structures and Cancer Conference. He is speaking about the power of #syntheticlethality, after Dr. Timothy Yap's presentation on Targeting ATR in the Clinic. #DRRSC24
In a major milestone for science, for medicine, and for patients, the world’s first CRISPR drug has been approved in the UK.
“A new treatment for sickle-cell disease and transfusion-dependent β-thalassemia has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) for patients aged 12 and over after a rigorous assessment of its safety, quality and effectiveness.”
Congratulations to the many scientists, doctors, patients, and industry leaders who made this development possible.🍻
https://t.co/pUL956YsG3
@biochemDheva I use both mac and pc for different purposes... and at some point your brain will know and can click it back anf forward, but it will take a while though.